The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD

Safety and Therapeutic Effect of Insulin Detemir in Taiwanese Patients With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets With OAD With/Without Once-daily NPH Insulin Treatment

The trial is conducted in Asia. The aim of the trial is to evaluate the effect of insulin detemir on blood glucose control in Taiwanese patients with type 2 diabetes failing on OAD with/without once-daily NPH Insulin treatment.

Inclusion Criteria:

• Type 2 diabetes
• HbA1C: 7.0-11.0%
• Previous diabetes treatment for at least 6 months
• BMI max. 35 kg/m2
• Treatment with an oral anti-diabetic drug (OAD)

Exclusion Criteria:

• Type 1 diabetes
• Receipt of any investigational drug within the last three months prior to this trial